BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33356170)

  • 1. Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.
    Ju Y; Edman MC; Guo H; Janga SR; Peddi S; Louie SG; Junge JA; MacKay JA; Hamm-Alvarez SF
    Biomacromolecules; 2021 Mar; 22(3):1102-1114. PubMed ID: 33356170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
    Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
    J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.
    Lee C; Guo H; Klinngam W; Janga SR; Yarber F; Peddi S; Edman MC; Tiwari N; Liu S; Louie SG; Hamm-Alvarez SF; MacKay JA
    Mol Pharm; 2019 Jul; 16(7):3024-3039. PubMed ID: 31095909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
    Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
    Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
    J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
    Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
    Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.
    Guo H; Ju Y; Choi M; Edman MC; Louie SG; Hamm-Alvarez SF; MacKay JA
    Biomaterials; 2022 Apr; 283():121441. PubMed ID: 35306230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
    Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
    Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
    Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
    Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
    Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
    Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome.
    Guo H; Lee C; Shah M; Janga SR; Edman MC; Klinngam W; Hamm-Alvarez SF; MacKay JA
    J Control Release; 2018 Dec; 292():183-195. PubMed ID: 30359668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.
    Ju Y; Guo H; Yarber F; Edman MC; Peddi S; Janga SR; MacKay JA; Hamm-Alvarez SF
    Bioconjug Chem; 2019 Sep; 30(9):2358-2372. PubMed ID: 31408605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
    Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
    Front Immunol; 2022; 13():833254. PubMed ID: 35309364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis.
    Singh Kakan S; Li X; Edman MC; Okamoto CT; Hjelm BE; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):1. PubMed ID: 37010857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.
    Schenke-Layland K; Xie J; Angelis E; Starcher B; Wu K; Riemann I; MacLellan WR; Hamm-Alvarez SF
    Matrix Biol; 2008 Jan; 27(1):53-66. PubMed ID: 17689946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.
    Schenke-Layland K; Xie J; Magnusson M; Angelis E; Li X; Wu K; Reinhardt DP; Maclellan WR; Hamm-Alvarez SF
    Exp Eye Res; 2010 Feb; 90(2):223-37. PubMed ID: 19852957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.
    Li X; Wu K; Edman M; Schenke-Layland K; MacVeigh-Aloni M; Janga SR; Schulz B; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5019-29. PubMed ID: 20463324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic examination of the NOD-mouse lacrimal glands, a potential model for idiopathic autoimmune dacryoadenitis in Sjogren's syndrome.
    Moore PA; Bounous DI; Kaswan RL; Humphreys-Beher MG
    Lab Anim Sci; 1996 Feb; 46(1):125-8. PubMed ID: 8699811
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
    Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
    Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
    Fu R; Edman MC; Hamm-Alvarez SF
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.